APS researcher breaks down the challenges of ISO 10993 for E&L device testing
It’s commonplace in the CRO community: While researchers recognize the value of strict FDA rules set for biocompatibility testing, they’reRead more.
The importance of rigorous ACT management during preclinical study procedures
During the preclinical testing of medical devices, one data point that regulatory officials are scrutinizing is the activated clotting timeRead more.
FAQs: Key facts to know about APS’s preclinical animal models
Whether you’ve contracted for pre-clinical testing before or you’re approaching the process for the first time, you may have keyRead more.
APS welcomes new Director of Toxicology, Dr. Harriet Kamendi
Dr. Harriet Kamendi is a graduate of Howard University’s Department of Pharmacology. Her research focused on characterizing the consequences ofRead more.
Fully equipped: APS features impressive range of research equipment
One of our most frequently asked questions at APS is the type and range of research equipment we feature onRead more.
Moving forward: 6 points to expect with your APS preclinical research program
If you’re coming to APS with one of your first new medical devices, you may be uncertain how your preclinicalRead more.
New APS canine model enables better arthritis research
When APS scientists approached their company executives six years ago about initiating a new procedure for the study of arthritis,Read more.
APS’ human blood loop assay points to the future of hemocompatibility testing
APS has found a way to improve hemocompatibility testing for researchers seeking final FDA approval on blood-contacting medical devices —Read more.